Product NDC: | 52533-034 |
Proprietary Name: | Labetalol HCl |
Non Proprietary Name: | Labetalol HCl |
Active Ingredient(s): | 5 mg/mL & nbsp; Labetalol HCl |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52533-034 |
Labeler Name: | Cantrell Drug Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120223 |
Package NDC: | 52533-034-20 |
Package Description: | 4 mL in 1 SYRINGE, PLASTIC (52533-034-20) |
NDC Code | 52533-034-20 |
Proprietary Name | Labetalol HCl |
Package Description | 4 mL in 1 SYRINGE, PLASTIC (52533-034-20) |
Product NDC | 52533-034 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Labetalol HCl |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120223 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Cantrell Drug Company |
Substance Name | LABETALOL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |